These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29257150)

  • 1. [Prognostic importance of cross-linked fibrin degradation products (D-dimer) in oncology].
    Deme D; Telekes A
    Magy Onkol; 2017 Dec; 61(4):319-326. PubMed ID: 29257150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.
    Yamashita Y; Wada H; Nomura H; Mizuno T; Saito K; Yamada N; Asanuma K; Usui M; Kamimoto Y; Matsumoto T; Ohishi K; Katayama N
    Intern Med; 2014; 53(5):413-9. PubMed ID: 24583428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism.
    Brotman DJ; Segal JB; Jani JT; Petty BG; Kickler TS
    Am J Med; 2003 Mar; 114(4):276-82. PubMed ID: 12681454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.
    Haas FJ; Schutgens RE; Biesma DH; Laterveer RH; Kluft C
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):297-304. PubMed ID: 23187785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical use of D-dimer in patients with cancer].
    Lecumberri R; Pegenaute C; Páramo JA
    Med Clin (Barc); 2011 Oct; 137(10):453-8. PubMed ID: 21074815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the combination of a bedside D-dimer assay and enzyme-linked immunosorbent soluble fibrin assay in patients with suspected venous thromboembolism.
    Brimble KS; Ginsberg JS
    Thromb Res; 1997 Nov; 88(3):291-7. PubMed ID: 9526949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-dimer in the year 2000: current data and new perspectives].
    Prisco D; Antonucci E; Marcucci R; Pepe G
    Ann Ital Med Int; 2000; 15(4):267-72. PubMed ID: 11202628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of D-dimer assays in the diagnosis of venous thrombosis.
    Dempfle CE
    Semin Thromb Hemost; 2000; 26(6):631-41. PubMed ID: 11140800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uses of different D-dimer levels can reduce the need for venous duplex scanning to rule out deep vein thrombosis in patients with symptomatic pulmonary embolism.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    J Vasc Surg; 2007 Sep; 46(3):526-32. PubMed ID: 17826240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of D-dimer in specific clinical conditions: a narrative review.
    Bruinstroop E; van de Ree MA; Huisman MV
    Eur J Intern Med; 2009 Sep; 20(5):441-6. PubMed ID: 19712840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.
    Bozic M; Blinc A; Stegnar M
    Thromb Res; 2002 Nov; 108(2-3):107-14. PubMed ID: 12590945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to use D-dimer in acute cardiovascular care.
    Giannitsis E; Mair J; Christersson C; Siegbahn A; Huber K; Jaffe AS; Peacock WF; Plebani M; Thygesen K; Möckel M; Mueller C; Lindahl B;
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):69-80. PubMed ID: 26450781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty.
    Mitani G; Takagaki T; Hamahashi K; Serigano K; Nakamura Y; Sato M; Mochida J
    J Orthop Surg Res; 2015 Nov; 10():172. PubMed ID: 26555394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
    Bach-Gansmo ET; Godal HC; Skjønsberg OH
    Thromb Res; 1998 Nov; 92(3):125-34. PubMed ID: 9806364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of a rapid semiquantitative D-dimer assay in critically ill patients with suspected venous thromboembolic disease.
    Kollef MH; Zahid M; Eisenberg PR
    Crit Care Med; 2000 Feb; 28(2):414-20. PubMed ID: 10708176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer measured at first venous thromboembolism is associated with future risk of cancer.
    Gran OV; Brækkan SK; Paulsen B; Skille H; Hansen JB
    Haematologica; 2016 Dec; 101(12):e473-e475. PubMed ID: 27612986
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of four strategies for diagnosing deep vein thrombosis: a cost-effectiveness analysis.
    Perone N; Bounameaux H; Perrier A
    Am J Med; 2001 Jan; 110(1):33-40. PubMed ID: 11152863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of elevated D-dimer in patients admitted to a large urban emergency department.
    Lippi G; Bonfanti L; Saccenti C; Cervellin G
    Eur J Intern Med; 2014 Jan; 25(1):45-8. PubMed ID: 23948628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are fibrin-related markers useful for the diagnosis of thrombosis?
    Wada H; Sakuragawa N
    Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.